A clinical trial called ALASCCA, which has been published in The New England Journal of Medicine, shows that patients with colorectal cancer, who have specific mutations in the PI3K signalling pathway ...

I don’t think I’m unique among old peeps when it comes to having no idea what happened to the world I used to know. OK, there’s some hyperbole in that statement. Obviously, in a rational sense, I know ...

Thirty-one of the 48 confirmed and probable cases of Ebola have died since the outbreak began in central Democratic Republic ...

Halsey told Zane Lowe that she’s “not allowed” to work on a new album due to the commercial performance of her last project, The Great Impersonator.

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer ...

The Department of Health and Human Services announced Thursday that it will decertify an organ procurement organization ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study ...

Following a whirlwind start to his reign as Danish national team coach, Kasper Hjulmand's tenure came to a disappointing end ...

New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic mutation, study finds.

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska Institute clinical trial found.